MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

09 Feb 2023 Evaluate
A decent increase of about 30.85% in the sales to Rs. 34322.60 millions was observed for the quarter ended December 2022. The sales figure stood at Rs. 26230.50 millions during the year-ago period.Modest increase of 24.61% in the Net Profit was reported from. 2398.10 millions to Rs. 2988.20  millions.Operating profit for the quarter ended December 2022 rose to 5519.50 millions as compared to 3472.00 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 34322.60 26230.50 30.85 92448.40 83999.80 10.06 112871.40 158236.80 -28.67
Other Income 787.30 1312.90 -40.03 1733.00 2576.10 -32.73 6709.90 5898.60 13.75
PBIDT 5519.50 3472.00 58.97 11846.80 12240.60 -3.22 21443.90 47096.90 -54.47
Interest 389.60 35.40 1000.56 660.10 120.40 448.26 169.40 286.80 -40.93
PBDT 5129.90 3436.60 49.27 11186.70 12120.20 -7.70 20527.40 46810.10 -56.15
Depreciation 1085.00 1012.00 7.21 3203.50 3140.30 2.01 4152.60 4880.00 -14.91
PBT 4044.90 2424.60 66.83 7983.20 8979.90 -11.10 16374.80 41930.10 -60.95
TAX 1056.70 26.50 3887.55 2127.10 2454.30 -13.33 1827.70 10801.00 -83.08
Deferred Tax -84.80 -861.60 -90.16 -204.70 -1088.60 -81.20 -1969.30 367.60 -635.72
PAT 2988.20 2398.10 24.61 5856.10 6525.60 -10.26 14547.10 31129.10 -53.27
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 16.08 13.24 21.49 12.81 14.57 -12.06 19.00 29.76 -36.17
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..